# C-Reactive Protein (CRP) in Obese Diabetic Women

> **NCT00262548** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Rosuvastatin; improvement of lipid profile

## Key facts

- **NCT ID:** NCT00262548
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2007-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262548, "C-Reactive Protein (CRP) in Obese Diabetic Women". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00262548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*